Skip to content

New Controlled Substance Continuing Education Requirements

On June 27, 2023, the Drug Enforcement Agency (DEA) is implementing the new controlled substance continuing education requirements:

The Mass Medical Society has provided the following program which will satisfy the one-time 8-hour training requirement for all DEA registered practitioners.

This is a Free 10-hour CME training on the treatment and management of patients with opioid or other substance disorders:

  1. NEJM Knowledge+ – Pain Management and Opioids

The Doctors Company (TDC) has also provided the following programs to assist in the completion of this one-time requirement:

  1. Safe Opioid Prescribing for Physicians and Dentists with 2.5 CME/CDE

  2. Pain Management – A closed Claim Analysis Looking at Risks and Lessons Learned with 1.25 CME

  3. Modules 1: Eliminating Stigma Through Clinical Understanding (Innovations and Smart Approaches in Safe Prescribing) with 0.5 CME

  4. Module 2: Alternatives to Opioids for Pain (Innovations and Smart Approaches in Safe Prescribing) with 0.5 CME

  5. Module3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing) with 0.75 CME

  6. Module 4: Recognition, Diagnosis, and Treatment of Substance Use Disorder (Innovations and Smart Approaches in Safe Prescribing) with 0.5 CME

  7. Module 5: Eliminating Stigma Through Clinical understanding of Substance Use Disorder (Innovations for Smart Approaches in Safe Prescribing) with 0.75 CME

Recommended Posts

2023 SCLLC Annual Meeting & CME Conference
The Doctor’s Advocate: Access to All Newsletters
Continuing Medical Education on Implicit Bias in Healthcare
BORM CME Requirements 2023